XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-based Compensation Expense for Employees and Non-employees

In the accompanying condensed consolidated statements of operations, the Company recognized stock-based compensation expense for its employees and non-employees as follows:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Research and development

 

$

1,823

 

 

$

1,174

 

 

$

5,262

 

 

$

2,653

 

General and administrative

 

 

1,457

 

 

 

900

 

 

 

4,177

 

 

 

3,956

 

Total stock-based compensation

 

$

3,280

 

 

$

2,074

 

 

$

9,439

 

 

$

6,609

 

Schedule of Estimated Grant-date Fair Value of Stock-based Awards Using Black-Scholes Option Pricing Model Assumptions

The fair values of the Company’s stock-based awards granted during the three and nine months ended September 30, 2021 and 2020 were estimated as of the grant date using the Black-Scholes option pricing model, based on assumptions as follows:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Expected term (in years)

 

6.0 – 6.1

 

 

5.5 – 7.0

 

 

5.3 – 7.0

 

 

5.3 – 7.0

 

Expected volatility

 

 

82 – 83

%

 

 

88 – 89

%

 

 

82 – 85

%

 

 

88 – 90

%

Risk-free interest rate

 

 

0.8 – 1.2

%

 

 

0.3 – 0.5

%

 

 

0.5 – 1.2

%

 

 

0.3 – 1.2

%

Expected dividend rate

 

 

%

 

 

%

 

 

%

 

 

%

 

Summary of Stock-Based Compensation Activity

A summary of activity under the 2008 Plan, 2015 Plan and 2018 Plan and related information is as follows:

 

 

 

 

 

 

 

Options Outstanding

 

 

 

Shares

Available

for Grant

 

 

Number

of Shares

Outstanding

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Weighted-

Average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value of

Outstanding

Options

(in thousands)

 

Outstanding — December 31, 2020

 

 

1,117,796

 

 

 

4,146,928

 

 

$

19.45

 

 

 

8.84

 

 

$

12,227

 

Awards authorized

 

 

945,139

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(1,048,610

)

 

 

1,048,610

 

 

 

17.39

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(51,827

)

 

 

13.09

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

263,444

 

 

 

(263,444

)

 

 

17.66

 

 

 

 

 

 

 

 

 

Outstanding — September 30, 2021

 

 

1,277,769

 

 

 

4,880,267

 

 

$

19.17

 

 

8.36

 

 

$

37,118

 

Exercisable — September 30, 2021

 

 

 

 

 

 

1,249,757

 

 

$

33.16

 

 

 

6.54

 

 

$

8,510

 

Vested and expected to vest — September 30, 2021

 

 

 

 

 

 

4,364,027

 

 

$

20.00

 

 

8.29

 

 

$

32,074